| Application no. and date | 92924669.2 (espacenet) (Federated) (European Patent Register), 19921204 | | Patent/reg. no. and date | DK/EP 0616525, 19950927 | | Publication date | 19940928 | | Priority no. and date | GB 9126444, 19911212, GB 9202522, 19920206 | | EP pub. no. and date |
EP 0616525 19940928 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo House, Berkeley Avenue, Greenford, Middlesex UB6 0NN , GB | | Applicant ref. no. | 17253 | | Inventor | AKEHURST, Rachel Ann, Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DP , GB,
TAYLOR, Anthony James, Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DP , GB,
WYATT, David Andrew, Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DP , GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 9/00 | | Title | Medikamenter | | Int. application no. | EP1992002810 | | Int. publication no. | WO1993011745 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
